Application 207065
- Type
- ANDA
- Sponsor
- ACCORD HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | TABLET;ORAL-28 | 0.02MG;0.1MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207065-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; LEVONORGESTREL | 0.02MG;0.1MG | TABLET / ORAL-28 | AB1 | 2020-08-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207065-001 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207065-001 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 0.02MG;0.1MG | TABLET / ORAL-28 | AB1 | 2020-08-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207065-001 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Apotex Corp. | a7a1fb54-5a24-40ff-b862-dea256309b7d | 2026-04-04 | Warnings, Adverse reactions | 207065 ANDA207065 |
| Levonorgestrel and Ethinyl Estradiol | LEVONORGESTREL AND ETHINYL ESTRADIOL | Naari Pte Limited | f1a3bfe0-1057-4120-be7e-d7b3570d5418 | 2024-04-22 | Warnings, Adverse reactions | 207065 ANDA207065 79929-004 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 79929-004 | Levonorgestrel and Ethinyl Estradiol | Levonorgestrel and Ethinyl Estradiol | Naari Pte Limited | ANDA | Current |